SCHEMBL13675516

SCHEMBL13675516

CCc1cccc(C(=O)N(C)CCN(C)CC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
PARP1 P09874 3/20 0.45
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
CNR2 P34972 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
PPARG P37231 1/20 0.40
BCL2 P10415 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
SMYD3 Q9H7B4 1/20 0.39
KAT6A Q92794 1/20 0.39
ROCK2 O75116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12334126 0.88 PARP1 (0.55) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL16015484 0.86 KMT2A (0.55) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL14117419 0.86 KMT2A (0.58) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL15676740 0.82 KMT2A (0.59) KMT2AMEN1PPARGL3MBTL1CDK4
SCHEMBL22352079 0.82 MEN1 (0.48) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL16900522 0.81 MEN1 (0.50) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL16015427 0.80 KMT2A (0.49) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL22753452 0.80 MEN1 (0.46) KMT2AMEN1PARP1HSD17B1HSD17B2
SCHEMBL322040 0.79 KMT2A (0.53) KMT2AMEN1HSD17B1HSD17B2CNR2
SCHEMBL15108901 0.79 KMT2A (0.58) KMT2AMEN1HSD17B1HSD17B2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270381-A1 Non-steroidal progesterone receptor modulators BAYER SCHERING PHARMA AG (DE) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270381-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, PGRMC2 KMT2A 1622/4885MEN1 2323/4885PARP1 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.